Hyphens Pharma licenses Winlevi® for all 10 ASEAN countries from Cosmo Pharmaceuticals
- Written by PR Newswire
- Winlevi® is a first-in-class topical drug for the treatment of acne approved by U.S. FDA in August 2020.
- It will reinforce our Proprietary Brand segment's dermatological franchise.
SINGAPORE, Dec. 23, 2022 /PRNewswire/ -- Hyphens Pharma International Limited ("Hyphens Pharma", or the "Company", and together with its subsidiaries, the "Group"), S...
